First Tracks Biotherapeutics Inc TRAX
$40.46 $2.05 (4.82%) 1D
Last Updated: Sep 04, 12:00 AM·NASDAQ
Pricing for US stocks is delayed by 24 hours
Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
Pricing
Company
About Musaffa
Investors
Build with us
Is First Tracks Biotherapeutics Inc Stock Halal?
Shariah Compliance Analysis of TRAX Stock
United States Health Care Small Cap No. As of September 2026, First Tracks Biotherapeutics Inc (TRAX) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. First Tracks Biotherapeutics Inc does not pass Musaffa's business and financial screening criteria.
First Tracks Biotherapeutics, Inc. engages in the research and development of immunology therapeutics for autoimmune and inflammatory diseases. The company is headquartered in San Diego, California and currently employs 104 full-time employees. The company went IPO on 2026-04-06. The firm's clinical-stage pipeline includes Rosnilimab, a selective pathogenic T cell depleter, for the treatment of moderate-to-severe rheumatoid arthritis (RA), ANB033, a CD122 antagonist, for celiac disease (CeD) and eosinophilic esophagitis (EoE), and ANB101, a blood dendritic cell antigen 2 (BDCA2) modulator. Rosnilimab is an IgG1 antibody that directly targets pathogenic T cells, such as activated Tph/Tfh and T effector cells, in the periphery or inflamed tissue. Rosnilimab is designed to selectively deplete pathogenic T cells while sparing non-pathogenic T cells, including naive T cells, to preserve overall immune function and restore immune homeostasis. Its molecules have applicability across a range of autoimmune and inflammatory diseases, including gastroenterology, rheumatology and other areas.
TRAX Shariah Compliance
Screening Methodology: AAOIFI
As of September 2026, First Tracks Biotherapeutics Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
First Tracks Biotherapeutics Inc (TRAX) Chart
Financial Metrics & Statements of First Tracks Biotherapeutics Inc (TRAX)
FAQ's for First Tracks Biotherapeutics Inc (TRAX)
- As of September 2026, First Tracks Biotherapeutics Inc TRAX is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes First Tracks Biotherapeutics Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in First Tracks Biotherapeutics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of First Tracks Biotherapeutics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of First Tracks Biotherapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of First Tracks Biotherapeutics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for First Tracks Biotherapeutics Inc (TRAX)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
